PFDSELECT MEDICAL RECEIVABLES 1011 LLC files Form D
Sold rose to $NaN (+$2.3M) in 143 days since the previous filing.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2026-03-24 | D/A | $19.3M | 96 | |
| 2026-08-14 | D/A | $21.6M | 91 | +$2.3M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor.
Sold rose to $NaN (+$2.3M) in 143 days since the previous filing.
Sold rose to $NaN (+$5.7M, +19 investors) in 650 days since the previous filing.
Sold rose to $NaN (+$20.9M, +97 investors) in 264 days since the previous filing.
Sold rose to $NaN (+$21.2M, +100 investors) in 387 days since the previous filing.
Sold rose to $NaN (+$35.7M, +153 investors) in 550 days since the previous filing.
| Gary L Ermoian | Executive Officer, Director |
| Eric E Hansen | Executive Officer |
| Robert E Pryke | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Robert E. Pryke, Vice President, PFD Capital Partners, Inc., Manager.
Relevant to: B2B software & services sales.
The issuer's phone number and address from the filing are shown to subscribers. See plans.